Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice

CompletedOBSERVATIONAL
Enrollment

157

Participants

Timeline

Start Date

August 12, 2014

Primary Completion Date

April 24, 2017

Study Completion Date

April 24, 2017

Conditions
Rheumatoid Arthritis
Interventions
DRUG

etanercept

etanercept 1 x 50 mg/week or 2 x 25mg/week

DRUG

etanercept

etanercept 1 x 50 mg/week or 2 x 25mg/week

Trial Locations (35)

1020

Centre Hospitalier Universitarie Brugmann, Brussels

1040

CHIREC, Brussels

2800

Louisastraat 18, Mechelen

3600

Biomedical Research Institute/ Department of Rheumatology, Genk

Private Practice Rheumatology, Genk

ReumaClinic, Genk

Reumatologie Associatie, Genk

4000

Centre Hospitalier Universitaire Sart Tilman, Department of Rheumatology, Liège

CHU Sart Tilman/ Department of Rheumatology, Liège

5030

Private Practice, Grand-Manil

5530

CHU Dinant Godinne, Yvoir

Avenue G Therasse 1, Yvoir

Cliniques Universitaires UCL de Mont-Godinne, Yvoir

6061

Hôpital Saintethérèse, Montigny Sur Sambre

6110

ISPPC de Charleroi, Montigny-le-Tilleul

7100

CHU Tivoli, La Louvière

8310

St. Lucas ZH, Assebroeck

8400

AZ Damiaan, Ostend

9000

Universitair Ziekenhuis Gent, Ghent

9200

AZ Sint Blasius, Dendermonde

9300

ASZ Aalst, Aalst

9900

AZ Alma, Eeklo

B-9300

Algemeen Stedelijk Ziekenhuis, Aalst

Onze Lieve Vrouw Ziekenhuis Aalst, Aalst

Onze Lieve Vrouw Ziekenhuis, Aalst

B-8310

St-Lucas Ziekenhuis, Assebroek

B-5020

Private Practice, Champion

B-3600

Private Practice, Genk

B-6060

GHdC, Gilly

Unknown

AZ Groeninge Campus Sint Maarten, Kortrijk

CHU, Liège

B-7000

CHU Ambroise Pare, Mons

B-2900

Office of Maenaut Kristien, Schoten

B-8700

Sint-Andries Ziekenhuis, Tielt

B-4800

CH Peltzer-Tourelle, Verviers

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02202837 - Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice | Biotech Hunter | Biotech Hunter